A Phase 1 trial of DARE-FRT1 intravaginal ring for fertility and pregnancy maintenance
Latest Information Update: 07 Apr 2025
At a glance
- Drugs Progesterone (Primary)
- Indications Preterm labour
- Focus Therapeutic Use
Most Recent Events
- 31 Mar 2025 According to a Dare Bioscience media release, the company is conducting activities necessary to enable phase 1 study.
- 13 Dec 2023 According to a Dare Bioscience media release, the company is eligible to receive up to a total of approximately $2 million in grant funding for its DARE-PTB1 program based on the grant application it submitted to support a DARE-PTB1 Phase 1 human clinical study.
- 30 Mar 2021 According to a Dare Bioscience media release, initiation of this trial is targeted for 2022.